Skip to main content
logo
Immunotech Biopharm Ltd (HKG:6978)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.3900
+0.0150 (4.00%)
Aug 26, 2026, 2:41 PM HKT

Immunotech Biopharm Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-159.4-175.07-200.9-231.05-274.22-345.15
Net Income
-171.55-230.79-186.91-334.82-318.11-354.22
Earnings Per Share
-0.29-0.42-0.35-0.65-0.62-0.69
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
61.75154.5757.49176.9779.46353.34
Total Debt
402.12440.26384.56457.17149.81111.05
Net Cash (Debt)
-340.38-285.7-327.07-280.2-70.35242.29
Net Cash Growth
------69.50%
Net Cash Per Share
-0.57-0.52-0.61-0.54-0.140.47

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
--97.29-125.74-163.63-180.92-254.65
Capital Expenditures
--14.06-27.26-19.58-68.15-146.01
Free Cash Flow
--111.35-153-183.21-249.07-400.67
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-77.9877.9877.9877.9877.98